Literature DB >> 974053

The scanning electronmicroscopy of human cervical mucus in the non-pregnant and pregnant states.

B Daunter, E N Chantler, M Elstein.   

Abstract

The ultrastructure of the high viscosity phase of human cervical mucus was studied by scanning electronmicroscopy. In the normal woman, sequential mucus samples taken throughout the menstrual cycle showed a honeycomb-like structure with interconnecting channels separated by thin membraneous walls. The diameter of the channels in the mucus was 2 to 6 mum in the early follicular phase, 30 to 35 mum in the late follicular phase and 4 to 6 mum in the luteal phase. During the first trimester of pregnancy and also at the beginning and end of the menstrual cycle a compact, dense form of mucus structure was observed. In women using either copper-releasing or pharmacologically inert intrauterine contraceptive devices (IUCDs), the basic structure was similar to that seen in normal women. The channel diameters were normal in women using the inert IUCD but the mucus from women using a copper-releasing IUCD showed a slight decrease in the late follicular phase channel diameter which was dependent on the time the device had been in place. Globular appendages to the membraneous walls of the mucus were observed in the presence of a copper-releasing IUCD.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974053     DOI: 10.1111/j.1471-0528.1976.tb00925.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  2 in total

1.  Differential binding of IgG and IgA to mucus of the female reproductive tract.

Authors:  Kelly M Fahrbach; Olga Malykhina; Daniel J Stieh; Thomas J Hope
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

2.  Cervical mucus properties stratify risk for preterm birth.

Authors:  Agatha S Critchfield; Grace Yao; Aditya Jaishankar; Ronn S Friedlander; Oliver Lieleg; Patrick S Doyle; Gareth McKinley; Michael House; Katharina Ribbeck
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.